Company intelligence / Profile preview

Integrity Bio

Camarillo, California, United States

Ownership: Private
Employees: ~116
Development stage: Other

Overview

Integrity Bio has formulated over 150 biologics, worked with more than 75 firms, and specializes in hard-to-formulate products in both liquid and lyophilized forms, supporting clients' preclinical and clinical products to commercial launch

Modalities: BiologicPeptidesProteinsAntibodyLipid nanoparticle delivery therapyVaccine
Industry: Contract Manufacturing Organization

Partnerships

Curia (parent company, post-acquisition)Numerous biotech and pharma firms, including both large and small companies

Beyond the preview

Go deeper on Integrity Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrity Bio.

Explore the full profile